Document:

Acknowledgement of the Georgia Tech research Corporation

 EXHIBIT 10.38 
 ACKNOWLEDGMENT 
 This ACKNOWLEDGMENT is executed as of August 12, 2005,
by GEORGIA TECH RESEARCH CORPORATION, a Georgia non-profit corporation (“GTRC”). 
 WHEREAS,
Dr. David N. Ku (“Ku”) is a full-time professor at the Georgia Institute of Technology (“GIT”); and 
 WHEREAS, GTRC is the assignee of all intellectual property rights that GIT may hold; and 
 WHEREAS,
Ku has assigned all of his right, title and interest in and to U.S. Patent No. 5,981,826, titled “Poly(Vinyl Alcohol) Cryogel” (the “GTRC Patent”), to GTRC; and 
 WHEREAS, Ku filed a certain continuation-in-part patent application based on the GTRC Patent that resulted in the issuance of U.S.
Patent No. 6,231,605, titled “Poly(Vinyl Alcohol) Hydrogel” (any related continuations, continuations-in-part, divisions thereof, reissues, renewals and extensions, as well as intellectual property that now exists or is hereafter
developed that is based on such patent is hereinafter collectively referred to as the “SaluMedica Patent”), all right, title and interest in and to which Ku has assigned to SaluMedica, LLC (“SaluMedica”); and 
 WHEREAS, GTRC and SaluMedica have entered into that certain License Agreement dated March 5, 1998 (as amended to date, the
“License Agreement”), pursuant to which GTRC has granted SaluMedica a certain license in and to the GTRC Patent, which license SaluMedica intends to sublicense to SpineMedica Corp., a Florida corporation (“SpineMedica”); and

 WHEREAS, Ku has filed Patent Application No. 10/658,932, titled “Flexible Spinal Disc,” relating to
a medical device for the replacement or treatment of intervertebral spinal discs (any patents issued in respect thereof and any intellectual property that now exists or is hereafter developed that is based on such patent or patent application is
hereinafter collectively referred to as the “Ku Patent Application”); 
 NOW, THEREFORE, GTRC hereby
acknowledges, agrees and represents as follows: 
 1. With respect to the License Agreement, GTRC hereby represents to SpineMedica that, to
GTRC’s knowledge at the date of this Acknowledgement: 
 (a) the License Agreement is in full force and effect and has
not been amended, modified or changed, whether in writing or orally, except pursuant to: (i) that certain First Amendment to License Agreement dated November 18, 1998, (ii) that certain Second Amendment to License Agreement dated
February 28, 2005; and (iii) that certain Third Amendment to License Agreement dated August 12, 2005; 
 (b)
neither GTRC nor, to GTRC’s knowledge, SaluMedica is in default in any way under the License Agreement, and, to GTRC’s knowledge, no event has occurred that is or would constitute a default by either GTRC or SaluMedica under the License
Agreement; and 
 (c) Except for the rights granted to SaluMedica under the License Agreement, GTRC has not granted any rights
in and to the GTRC Patent to any third party that allow any such third party to use or sublicense the GTRC Patent for commercial purposes. 
  

 1 of 2 

 2. GTRC acknowledges that SaluMedica has granted or will grant to SpineMedica a sublicense to, among
other things, practice and use the technology related to the GTRC Patent pursuant to the terms set forth in a license agreement (the “Sublicense Agreement”). GTRC hereby acknowledges and agrees that, to GTRC’s knowledge at the date of
this Acknowledgement, the grant to SpineMedica by SaluMedica of, among other things, an exclusive, fully-paid, royalty-free, irrevocable sublicense to practice and use the technology related to the GTRC Patent, specifically for practice and use in
the field of use consisting of all neurological and orthopedic uses, including muscular and skeletal uses, related to the human spine, is not in conflict with any agreement or understanding between or among GTRC or GIT and SaluMedica or Ku.
Notwithstanding the foregoing, it is understood that the irrevocable license between SaluMedica and SpineMedica pertains only to the license grant under the Sublicense Agreements, and does not affect GTRC’s rights to revoke the license granted
to SaluMedica under the License Agreement. 
 3. GTRC hereby acknowledges and agrees that, to GTRC’s knowledge at the date of this
Acknowledgement, it has no right, title and interest in or to the Ku Patent Application. 
 IN WITNESS WHEREOF, GTRC
has executed this Acknowledgment as of the date first written above. 
  

			
	 GEORGIA TECH RESEARCH CORPORATION

		
	By:	 	 /s/ Lauren MacLanahan

	Name:	 	 Lauren MacLanahan

	Its:	 	 Technology Licensing Associate

		
	By:	 	 /s/ G. Duane Hutchison

	Name:	 	 G. Duane Hutchison

	Its:	 	 Asst. Secretary & Asst. Treasurer

  

			
	 Read and Understood:

	
	 SALUMEDICA, LLC

		
	 By:
	 	 /s/ Eric D. Ranney

		 	 Eric D. Ranney, Manager

		
	 By:
	 	 /s/ Robert B. Braden

		 	 Robert B. Braden, Manager

  

 2 of 2License Agreement

 EXHIBIT 10.39 
 LICENSE AGREEMENT 
 THIS AGREEMENT is made and entered into the 5th day of March, 1998 (hereinafter the “Effective Date”) by and between GEORGIA TECH RESEARCH CORPORATION, a non-profit corporation organized and existing under
the laws of the State of Georgia and having its principal offices at the Georgia Institute of Technology (hereinafter “GIT”), Centennial Research Building, Atlanta, Georgia 30332-0415 (hereinafter “GTRC”) and RESTORE
THERAPEUTICS, INC., a corporation incorporated under the laws of the State of Georgia, and having its registered office in that State at Suite 2100, The Equitable Building, 100 Peachtree Street, Atlanta, Georgia 30303-1962 (hereinafter
“RT”). 
 W I T N E S S E T H 
 WHEREAS, GTRC owns and wants to provide for the commercialization of a certain invention entitled “Poly (Vinyl Alcohol)
Cryogel”, which is the subject of GTRC Invention Disclosure number 1837 and U.S. Patent Application Number 08/932,029 (hereinafter the “Invention”). 
 WHEREAS, GTRC has available to it certain know-how, technology, trade secrets and methods (hereinafter “Know-how”) which relate to the Invention; and 
 WHEREAS, RT wishes to utilize the Invention and Know-how related to the Invention (hereinafter the “Technology”) to
achieve the development, manufacture, and sale of Products containing the Technology. 
 NOW, THEREFORE, GTRC and RT
in consideration of the foregoing and the mutual promises contained herein and intending to be legally bound hereby agree as follows: 
  

	1.	 DEFINITIONS 

 As used
herein: 
  

	 	1.1	 “Net Selling Price” shall mean the gross sales by RT of the Products, less only usual trade discounts, sales tax which the seller has to pay or absorb,
customs duties and transportation and insurance charges, if not included in the gross price, and any and all Federal, foreign, State or local taxes (except income tax) incurred by the seller on such sales. 

  

	 	1.2	 “Patent” shall mean any issued letters patent disclosing and claiming the Invention, including a reissued patent, a patent issuing from a continuation
application, divisional application or continuation-in-part application, and means any foreign patent similar thereto. 

  

	 	1.3	 “Products” shall mean any method through which the Technology is commercialized and utilized by RT. 

  

 -1- 

	 	1.4	 “Sales”, “Sell”, or “Sold” shall mean any sale, transfer, lease, license, permission to use or other transfer of the right of
possession or other conveyance by RT. 

  

	 	1.5	 “Proprietary Information” shall mean information and trade secrets owned or controlled by GTRC at any time during the term of this Agreement, which
relates to the Inventions covered by the Licensed Patents, including but not limited to, invention records, research records and reports, engineering and technical data, designs, production specifications, processes, methods, procedures, facilities
and know-how. 

  

	 	1.6	 “Territory” shall mean the world. 

  

	2.	 GRANT OF LICENSE 

  

	 	2.1	 With respect to the Technology to which GTRC has exclusive rights, GTRC hereby grants to RT an exclusive, nontransferable, royalty-bearing license, with a right
of sublicense, to make, sell, and use Products throughout the Territory. RT shall not export any Product or enter into any sublicense without fully and completely complying with any and all United States export or munitions control regulations and
laws. 

  

	 	2.2	 RT acknowledges and agrees that by entering into this agreement, it may be precluded from receiving sub-contracts from the Georgia Institute of Technology funded
by an agency of the federal government which it might otherwise be able to receive on a sole basis. 

  

	 	2.3	 Any provision of this Agreement to the contrary notwithstanding, GTRC reserves an irrevocable, nonexclusive, royalty-free, nontransferable license for itself and
GIT to use the Technology for research and educational purposes. 

  

	3.	 CONSIDERATION 

  

	 	3.1	 In consideration of the granting herein of the License as described in Article 2, RT shall pay GTRC: 

  

	 	3.1.1	 One Thousand U.S. Dollars ($1,000) within seven (7) days of the Effective Date of this Agreement; and 

  

	 	3.1.2	 the Royalties as set forth below in Article 5. 

  

	 	3.2	 As additional consideration RT shall issue to GTRC a sufficient number of shares of the common stock of RT so that GTRC will own Five percent (5%) of the
total number of such shares issued by RT. Thereafter, should RT sell or otherwise issue additional shares of stock, a proportionate number of shares shall be issued to GTRC so that Five percent (5%) ownership interest in RT by GTRC shall be
maintained at all times. Provided, however, that when the book value of issued shares of common stock exceeds Five Million U.S. Dollars ($5,000,000), RT shall have no further obligation to issue shares of common stock to GTRC for and in 

  

 -2- 

	 	 
consideration of the license granted herein. Provided further, that in such event, GTRC shall be deemed to have and is hereby granted an option to purchase a
sufficient number of shares in any subsequent issue or issues at the book value of such shares to maintain its Five percent (5%) ownership of RT. 

  

	4.	 SUBLICENSES 

  

	 	4.1	 Subject to this Paragraph, RT may grant sublicenses to persons or entities specifically approved in writing by GTRC, which approval shall not be unreasonably
withheld, provided that each sublicense contains a provision that such sublicense and the rights thereby granted are personal to the sublicense thereunder and such sublicense cannot be further assigned or sublicensed. 

 

	 	4.2	 Any sublicense granted pursuant to this Article shall be in accordance with the terms and conditions of this Agreement and shall at a minimum contain the same
protection for GTRC’s Proprietary Information as is set forth herein. 

  

	 	4.3	 In respect of any sublicense granted by RT in accordance with this Article, RT shall promptly pay to GTRC an amount equal to Forty percent (40%) of any lump
sum or other payment howsoever calculated, made by the sublicense thereunder in consideration for the grant of such sublicense to it by the RT. 

  

	5.	 ROYALTIES 

  

	 	5.1	 RT shall pay GTRC royalties at the rate of Four percent (4%) of the Net Selling Price of Products sold by RT or any sublicense under this Agreement.

  

	 	5.2	 All payments to GTRC under this Agreement shall be made in U.S. dollars at GTRC’s address for notice. Such payments shall be paid to GTRC quarterly on a
calendar year basis. Payment for sales made during each quarter of each calendar year shall be made to GTRC within thirty (30) days after the last day of each quarter. 

  

	 	5.3	 RT shall pay all royalties due hereunder to GTRC and GTRC shall not be required to look to any other entity for payment. 

  

	 	5.4	 If other technologies on which royalty is payable need to be licensed to work the technology, then the royalty payable shall be reduced by such other necessary
royalty, except that at no time shall the royalty payable to less than Two percent (2%). 

  

	6.	 ACCOUNTS 

  

	 	6.1	 Not later than March 1 of each calendar year RT shall furnish to GTRC a statement showing the total net sales of Products by RT during the immediate
preceding calendar year, and the royalties payable thereon calculated in the manner required in Article 5. 

  

 -3- 

	 	6.2	 RT shall keep at its usual place of business true and particular accounts of all matters connected with the use of the Technology and the manufacture and sale of
all Products and shall keep books of account relating to royalties payable hereunder containing true entries complete in every particular as may be necessary or proper for enabling the amount of such royalties to be conveniently ascertained.

  

	 	6.3	 If requested in writing by GTRC, RT shall at all reasonable times produce evidence of the matters referred to in Article 6 and shall permit such evidence to be
verified by an independent accountant to be selected and paid for by GTRC. RT shall give such accountant all necessary facilities for verifying such evidence and shall give such information as may be necessary or proper to enable the amount of the
royalties to be verified. 

  

	7.	 IMPROVEMENTS 

  

	 	7.1	 Should RT or any consultant or employee of RT during the term of this Agreement make or discovery any improvement in connection with the Technology, whether
patentable or not, which if practiced would constitute an infringement of any Patent of the Technology, RT shall forthwith disclose or cause the same to be disclosed to GTRC, and such improvement shall be deemed to be a part of the
“Technology” and shall be subject to the terms hereof for the purpose of calculating royalties hereunder. The foregoing notwithstanding, RT shall own all right, title and interest in any such discovery or improvement. However, RT shall
make available to GTRC and GIT any improvements or modifications it makes to the Technology and grants to GTRC and GIT an irrevocable, non-exclusive, royalty-free, non-transferable license to use the improvements throughout the world for educational
and research and development purposes only. If so requested by GTRC, RT shall make available or supply to GTRC such information or data as is necessary or convenient for the proper understanding or use of such discovery or improvement.

  

	 	7.2	 If GTRC makes or discovers any improvement developed either by David N. Ku, Linda G. Braddon or David Wootton or under their supervision in connection with the
Technology, whether patentable or not, which if practiced would constitute an infringement of any Patent on the Technology, GTRC shall, subject to the pre-existing rights of any third party, forthwith disclose or cause the same to be disclosed to RT
and such improvement shall be deemed to be included in the term “Technology” and to be included in this Agreement and be subject to the terms hereof and any application for letters patent or other equivalent protection made in respect
thereof shall be treated as if it were included in the term “Patent”. The costs of prosecuting such applications for letters patent or equivalent protection and maintaining the letters patent issuing from such applications shall be borne
by RT during the term of this agreement, subject to the prior approval of RT to such applications. Any such discovery or improvement shall belong to and be the sole and exclusive property of GTRC. 

  

 -4- 

	8.	 CONFIDENTIALITY 

  

	 	8.1	 RT shall not disclose any Proprietary Information pertaining to the Invention other than to RT employees who must have access to such Information in order to
carry out RT’s obligations under this Agreement and to potential sublicensees of the Technology, provided such disclosure is in accordance with Paragraph 8.3 hereof. Prior to disclosure of Proprietary Information to RT employees, such employees
shall be under a written obligation of confidentiality to RT at least as restrictive as the provisions contained herein. Proprietary Information shall be maintained in confidence by RT for so long as such Information is maintained in confidence by
GTRC. 

  

	 	8.2	 To protect GTRC’s Proprietary Information, RT shall adopt reasonable security measures commonly observed in industries that rely on Proprietary Information.
These measures shall include, but not be limited to, restricted access to such information, marking such information, and the selective destruction of sensitive materials. Upon termination of this Agreement, RT shall return or destroy all documents
or materials embodying GTRC Proprietary Information. 

  

	 	8.3	 Any disclosure of Proprietary Information by RT to potential sublicensees of the Technology shall be prohibited, unless such potential sublicense has signed an
agreement which imposes obligations of confidentiality and nonuse at least as restrictive as those imposed on RT hereunder. 

  

	9.	 INITIAL DEVELOPMENT AND FULL USE OF TECHNOLOGY 

  

	 	9.1	 As soon as reasonably practicable after the Effective Date of this Agreement, but not later than Four (4) years after the Effective Date hereof, RT shall
take steps to meet the reasonable requirements of the market by offering for sale Products in sufficient quantities to meet a reasonable public demand. 

  

	 	9.2	 Should GTRC not receive at least Ten Thousand U.S. Dollars ($10,000) in royalty payments from RT within the first Twenty-four (24) months after the first
sale of Products or Four (4) years from the Effective Date of this Agreement, which is sooner, and should GTRC not receive at least Twenty Thousand U.S. Dollars ($20,000) in royalty payments during each twelve (12) month period thereafter,
GTRC shall have the option to allow this Agreement to continue in full force and effect or to convert the license granted hereunder to a nonexclusive license upon written notice to RT. 

  

	10.	 CONSULTING 

  

	 	10.1	 Any use of GIT personnel as consultants shall be on a noninterfering basis with normal GIT activities. RT shall make arrangements with GIT to assure
noninterference. Compensation and travel reimbursement are to be paid directly to consultants by RT. The relationship between RT and its consultants shall be outside the scope of this Agreement, except that such consulting agreements shall 

  

 -5- 

	 	 
not under any circumstances grant RT rights to any GIT/GTRC intellectual property. 

  

	11.	 PROTECTION OF INTELLECTUAL PRPOERTY 

  

	 	11.1	 GTRC shall file any and all future patent applications, trademark registrations or copyright registrations (hereinafter “Intellectual Property
Protection”), domestic and/or foreign, in GTRC’s name to protect the Technology and/or improvements to the Technology licensed hereunder. Subject to the prior approval of RT to such applications, RT shall be responsible for all costs, fees
and expenses incurred in connection with the filing, prosecution and maintenance of all Intellectual Property Protection and the maintenance of any patent, trademark or copyright issuing thereon, other than those costs relating to U.S. Patent
Application Number 08/932,029. 

  

	 	11.2	 If, at any time during the term of this Agreement, RT elects to abandon its right in any pending Intellectual Property Protection or any patent, trademark or
copyright issued thereon, either domestic or foreign, it shall notify GTRC of that decision at least two (2) months prior to any deadline for filing any response or taking any other action necessary to maintain any such Intellectual Property
Protection. Thereafter, GTRC shall have the right and option to take over the sole and exclusive responsibility for the prosecution of any such Intellectual Property Protection and/or the maintenance of any such patent, trademark or copyright solely
at GTRC’s expense and in such an event the rights granted under this Agreement shall become nonexclusive for such country or countries of the Territory. 

  

	 	11.3	 If patent, trademark or copyright protection is obtained for the Technology and/or improvements to the Technology, RT shall cooperate with RT in enforcing or
policing such protection as provided in Article 12 herein and by taking all appropriate measures including marking trade secrets and other Proprietary Information as required and taking other measures as mutually agreed to by GTRC and RT.

  

	12.	 NOTICE OF INFRINGEMENT AND ENFORCEMENT OF RIGHTS 

  

	 	12.1	 Immediately upon RT’s learning of any infringement, misappropriation or other unauthorized use of GTRC’s Proprietary Information, and/or Patents,
copyrights or trademarks pertaining to GTRC’s Invention licensed hereunder (hereinafter “Intellectual Property Rights”), RT shall promptly inform GTRC. 

  

	 	12.2	 If RT and GTRC agree to jointly pursue enforcement of GTRC’s Intellectual Property Rights, then the parties hereto shall share equally all costs, fees
and/or expenses incurred in connection with enforcement of GTRC’s Intellectual Property Rights provided only that GTRC’s maximum exposure for such costs, fees and expenses shall be the amount of royalties paid and/or payable to GTRC by RT
hereunder. Any payments accruing from such action to enforce GTRC’s 

  

 -6- 

	 	 
Intellectual Property Rights shall be paid to RT and GTRC in proportion to the parties’ respective contributions to all costs, fees and/or expenses
incurred in such action. 

  

	 	12.3	 In the event that either party shall determine, for any reason, that it does not choose to enforce GTRC’s Intellectual Property Rights, then that party
shall promptly notify the other party of such decision. The party choosing to enforce GTRC’s Intellectual Property Rights may then proceed with such enforcement action solely at its own expense and any and all recoveries shall be awarded solely
and exclusively to that party. 

  

	13.	 INDEMNITY 

  

	 	13.1	 RT hereby indemnifies and holds harmless GTRC, GIT, and the Board of Regents of the University System of Georgia, and their employees, officers, board members
and agents (hereinafter “Indemnitees”) from and against all claims, suits, liabilities, damages, costs, fees, expenses or losses arising out of or resulting from RT’s performance of this agreement, including but not limited to any
third party claims against indemnities for any damages, losses or liabilities whatsoever with respect to death or injury to any person and damage to any property arising from the possession, use or operation of Products produced or sold by RT or its
sublicensees or their customers in any manner whatsoever. 

  

	14.	 DISCLAIMER, WARRANTY AND LIMITATION OF LIABILITY 

  

	 	14.1	 EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, GTRC DISCLAIMS ANY AND ALL PROMISES, REPRESENTATIONS AND WARRANTIES WITH RESPECT TO THE TECHNOLOGY, INCLUDING
ITS CONDITION, CONFORMITY TO ANY REPRESENTATION OR DESCRIPTION, THE EXISTENCE OF ANY LATENT OR PATENT DEFECTS THEREIN AND ITS MERCHANTABILITY OR FITNESS FOR A PARTICULAR USE OR PURPOSE. 

  

	 	14.2	 In no event shall GTRC be liable for any use by RT of the technology or any loss, claim, damage or liability, of whatsoever kind or nature, which may arise from
or in connection with RT’s performance under this Agreement. 

  

	15.	 TRADEMARK 

  

	 	15.1	 Except for the purposes of identifying the Technology, no right, title interest or license to any trademark or service mark, is granted to RT.

  

	16.	 RELATIONSHIP BETWEEN GTRC AND RT 

  

	 	16.1	 GTRC and RT are and shall remain independent contractors and nothing herein shall create a partnership or joint venture between GTRC and RT.

  

 -7- 

	17.	 ADVERTISING, PUBLICITY AND PUBLICATIONS 

  

	 	17.1	 Except as otherwise provided herein, RT shall not use the names of Georgia Tech Research Corporation, the Georgia Institute of Technology, Georgia Tech, the
Georgia Tech Foundation or any of their respective affiliates or divisions in any advertisement or sales materials without the prior written consent of GTRC. 

  

	 	17.2	 In any publication (including advertisements, sales and trade literature and instruction manuals) relating to the Invention used pursuant to this Agreement, RT
shall give due credit to GTRC, as owner and licensor and in the case of professional journals, trade publications and editorials to David N. Lu, Linda G. Braddon and David Wootton, as inventors of the Invention. 

  

	 	17.3	 GTRC and the Inventors shall have the right to publish papers and other scholarly materials on the Technology in the appropriate literature. Such publication
shall in no event disclose proprietary or confidential information of the other party. GTRC and GIT may catalog and place such publications in the GIT library. RT shall have the right to review materials related to the Technology prior to
publication. 

  

	18.	 TERM AND TERMINATION 

  

	 	18.1	 This Agreement shall commence on the Effective Date of this Agreement and shall continue until the expiration of the last expiring patent covering any of the
Technology licensed hereunder. Notwithstanding the foregoing, the obligations of the parties under Articles 5, 6, 8, 13, 14 and 18 shall survive any termination of this Agreement. 

  

	 	18.2	 In the event of the breach of a material obligation hereunder by either party, the nonbreaching party shall inform the alleged breaching party of said breach in
writing. The alleged breaching party shall have thirty (30) days from the date of said notification during which time to cure the breach. In the event the alleged breaching party does not cure the breach within thirty (30) days, the
nonbreaching party may terminate the Agreement. 

  

	 	18.3	 RT shall, within ten (10) days of termination of this Agreement for any reason, deliver to GTRC all written documentation in the possession of RT which
contains Proprietary Information pertaining to the Technology. 

  

	19.	 NOTICES 

  

	 	19.1	 All notices required or permitted under this Agreement shall be in writing and shall be delivered personally or sent by certified registered mail to RT or GTRC
at the addresses set forth below: 

  

 -8- 

 GTRC: 
 GEORGIA TECH RESEARCH CORPORATION 
 Centennial Research Building 
 Georgia Institute of
Technology 
 Atlanta, Georgia 30332-0415 
 Attn: Director, Technology Licensing 
 RT: 
 RESTORE THERAPEUTICS, INC. 
 Suite 2100 
 The Equitable Building 
 100 Peachtree Street 
 Atlanta, Georgia 30303-1162

 Attn: David N. Ku, Ph.D., M.D. 
  

	20.	 WAIVER 

  

	 	20.1	 Waiver by either party of any term or provision of this Agreement shall not constitute a continuing waiver thereof nor any further or additional rights such
party may hold under this Agreement. 

  

	21.	 SEVERABILITY 

  

	 	21.1	 If any provision of this Agreement shall be held to be invalid, illegal or unenforceable, the validity, illegality or unenforceability of the remaining
provisions shall not in any way be affected or impaired. 

  

	22.	 GOVERNING LAW 

  

	 	22.1	 This Agreement shall be construed in accordance with the laws of the State of Georgia, U.S.A. 

  

	23.	 ENTIRE AGREEMENT 

  

	 	23.1	 This Agreement is the complete and exclusive statement between the parties relating to the subject matter hereof, and supersedes all prior understandings,
communications, or representations, either oral or written, between the parties. This License Agreement may not be modified or altered except by a written instrument duly executed by RT and GTRC. 

  

	24.	 CUMULATIVE RIGHTS 

  

	 	24.1	 Unless expressly stated to the contrary elsewhere in this Agreement, all rights, powers and privileges conferred hereunder upon the parties hereto shall be
cumulative and not restrictive of those given by law. 

  

 -9- 

	25.	 SECTION HEADINGS 

  

	 	25.1	 Section headings have been inserted herein for convenience of reference only and shall in no way modify or restrict any of the terms or provisions of this
Agreement. 

  

	26.	 ASSIGNMENT 

  

	 	26.1	 Subject to this Paragraph, the License is personal to RT. It is expressly understood by the parties that the License may be assigned to the Georgia Institute of
Technology or the Board of Regents of the University System of the State of Georgia. Except as otherwise agreed herein, this Agreement may not be assigned by either party without the prior written consent of the other. 

 

	27.	 SUCCESSORS AND ASSIGNS 

  

	 	27.1	 This Agreement shall bind and inure to the benefit of the parties hereto and their respective successors and permitted assigns, but nothing contained herein
shall be deemed to permit assignment by either party except as otherwise permitted in this Agreement. 

  

	28.	 INTERPRETATION 

  

	 	28.1	 In the interpretation of this Agreement, words importing the singular or plural number shall be deemed to import the plural and singular number respectively,
words denoting gender shall include all genders and references to persons shall include corporations or other bodies and vice versa. 

  

	29.	 FORCE MAJEURE 

  

	 	29.1	 Neither party shall be held in breach of this Agreement because of acts or omissions caused by any act of God or other cause beyond the control of the parties,
including, but not limited to, fire, floods, labor disputes, or other unforeseen circumstances. 

 IN
WITNESS WHEREOF, the parties have hereunto set their hands and seals and duly executed this Agreement effective as of the date first above written. 
  

 -10- 

							
	 GEORGIA TECH RESEARCH CORPORATION
	 	 RESTORE THERAPEUTICS, INC.

				
	 By:
	 	 /s/ Barry Rosenberg
	 	 By:
	 	 /s/ David N. Ku

				
	 Typed Name:
	 	 Barry Rosenberg
	 	 Typed Name:
	 	 David N. Ku

				
	 Title:
	 	 Director, Technology Licensing
	 	 Title
	 	 President

				
	 Date:
	 	 3/5/98
	 	 Date:
	 	 2/27/98

				
	 By:
	 	 /s/ J.W. Dees
	 		 	
				
	 Typed Name:
	 	 J.W. Dees
	 		 	
				
	 Title:
	 	 Asst. Secretary
	 		 	
				
	 Date:
	 	 3/5/98
	 		 	

  

 -11-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]